← Leaderboards
Balaji Sitharaman
State University New York Stony Brook
$4,161,114
Attributed
$5,806,734
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2010–19$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$5,806,734 · 5
By mechanism
R44$2,984,964 · 2
DP2$2,355,000 · 1
R43$306,277 · 1
R41$160,493 · 1
Top collaborators
- Jimmy Deon Toussaint4 shared
- Laurie T Krug1 shared
Most similar at State University New York Stony Brook
Same institution · by research overlap
- Robert C. Rizzo$7,144,550
- Carlos Simmerling$6,133,512
- Beverly Jan Gnadt$3,267,897
- Laurie T Krug$2,581,773
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseNanoparticleTechnologyMonitorIn VitroDiagnosticIn VivoNatural GraphiteWaterImageLeadPathologyAnimal ModelInjuryChronic Kidney FailureKidney DiseasesAcuteAnimalsDextransKidney FailureFda ApprovedDoseCarbonIodine
Grant awards (7)
A Graphene Nanoparticle-Based X-ray Computed Tomography Contrast Agent ForSubjects At Risk for Contrast Induced Nephropathy$748,000
R44 · FY2019 · DK
A Graphene Nanoparticle-Based X-ray Computed Tomography Contrast Agent ForSubjects At Risk for Contrast Induced Nephropathy$748,000
R44 · FY2018 · DK
CRISPR-Cas9 Systems Delivered by Targeted Nanoparticles to Eradicate Herpesvirus Pathogens$306,277
R43 · FY2017 · AI · contact PI
Preclinical Efficacy And Safety Evaluation Of Graphene Nanoparticle-based Magnetic Resonance Imaging Contrast Agent For Diagnosis of Renal Failure$717,997
R44 · FY2016 · DK · contact PI
Preclinical Efficacy And Safety Evaluation Of Graphene Nanoparticle-based Magnetic Resonance Imaging Contrast Agent For Diagnosis of Renal Failure$770,967
R44 · FY2015 · DK · contact PI
Preclinical Efficacy And Safety Evaluation Of Graphene Nanoparticle-based Magneti$160,493
R41 · FY2013 · DK · contact PI
Nanotechnology-based Theranostic Technology for Bone Tissue Engineering$2,355,000
DP2 · FY2010 · OD · contact PI